Cargando…
Angiogenin and Osteoprotegerin are type II muscle specific myokines protecting pancreatic beta-cells against proinflammatory cytokines
Tissue cross-talk is emerging as a determinant way to coordinate the different organs implicated in glucose homeostasis. Among the inter-organ communication factors, muscle-secreted myokines can modulate the function and survival of pancreatic beta-cells. Using primary human myotubes from soleus, va...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030123/ https://www.ncbi.nlm.nih.gov/pubmed/29968746 http://dx.doi.org/10.1038/s41598-018-28117-2 |
_version_ | 1783337083615576064 |
---|---|
author | Rutti, Sabine Dusaulcy, Rodolphe Hansen, Jakob S. Howald, Cédric Dermitzakis, Emmanouil T. Pedersen, Bente K. Pinget, Michel Plomgaard, Peter Bouzakri, Karim |
author_facet | Rutti, Sabine Dusaulcy, Rodolphe Hansen, Jakob S. Howald, Cédric Dermitzakis, Emmanouil T. Pedersen, Bente K. Pinget, Michel Plomgaard, Peter Bouzakri, Karim |
author_sort | Rutti, Sabine |
collection | PubMed |
description | Tissue cross-talk is emerging as a determinant way to coordinate the different organs implicated in glucose homeostasis. Among the inter-organ communication factors, muscle-secreted myokines can modulate the function and survival of pancreatic beta-cells. Using primary human myotubes from soleus, vastus lateralis and triceps brachii muscles, we report here that the impact of myokines on beta-cells depends on fiber types and their metabolic status. We show that Type I and type II primary myotubes present specific mRNA and myokine signatures as well as a different sensitivity to TNF-alpha induced insulin resistance. Finally, we show that angiogenin and osteoprotegerin are triceps specific myokines with beta-cell protective actions against proinflammatory cytokines. These results suggest that type I and type II muscles could impact insulin secretion and beta-cell mass differentially in type 2 diabetes through specific myokines secretion. |
format | Online Article Text |
id | pubmed-6030123 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-60301232018-07-11 Angiogenin and Osteoprotegerin are type II muscle specific myokines protecting pancreatic beta-cells against proinflammatory cytokines Rutti, Sabine Dusaulcy, Rodolphe Hansen, Jakob S. Howald, Cédric Dermitzakis, Emmanouil T. Pedersen, Bente K. Pinget, Michel Plomgaard, Peter Bouzakri, Karim Sci Rep Article Tissue cross-talk is emerging as a determinant way to coordinate the different organs implicated in glucose homeostasis. Among the inter-organ communication factors, muscle-secreted myokines can modulate the function and survival of pancreatic beta-cells. Using primary human myotubes from soleus, vastus lateralis and triceps brachii muscles, we report here that the impact of myokines on beta-cells depends on fiber types and their metabolic status. We show that Type I and type II primary myotubes present specific mRNA and myokine signatures as well as a different sensitivity to TNF-alpha induced insulin resistance. Finally, we show that angiogenin and osteoprotegerin are triceps specific myokines with beta-cell protective actions against proinflammatory cytokines. These results suggest that type I and type II muscles could impact insulin secretion and beta-cell mass differentially in type 2 diabetes through specific myokines secretion. Nature Publishing Group UK 2018-07-03 /pmc/articles/PMC6030123/ /pubmed/29968746 http://dx.doi.org/10.1038/s41598-018-28117-2 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Rutti, Sabine Dusaulcy, Rodolphe Hansen, Jakob S. Howald, Cédric Dermitzakis, Emmanouil T. Pedersen, Bente K. Pinget, Michel Plomgaard, Peter Bouzakri, Karim Angiogenin and Osteoprotegerin are type II muscle specific myokines protecting pancreatic beta-cells against proinflammatory cytokines |
title | Angiogenin and Osteoprotegerin are type II muscle specific myokines protecting pancreatic beta-cells against proinflammatory cytokines |
title_full | Angiogenin and Osteoprotegerin are type II muscle specific myokines protecting pancreatic beta-cells against proinflammatory cytokines |
title_fullStr | Angiogenin and Osteoprotegerin are type II muscle specific myokines protecting pancreatic beta-cells against proinflammatory cytokines |
title_full_unstemmed | Angiogenin and Osteoprotegerin are type II muscle specific myokines protecting pancreatic beta-cells against proinflammatory cytokines |
title_short | Angiogenin and Osteoprotegerin are type II muscle specific myokines protecting pancreatic beta-cells against proinflammatory cytokines |
title_sort | angiogenin and osteoprotegerin are type ii muscle specific myokines protecting pancreatic beta-cells against proinflammatory cytokines |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030123/ https://www.ncbi.nlm.nih.gov/pubmed/29968746 http://dx.doi.org/10.1038/s41598-018-28117-2 |
work_keys_str_mv | AT ruttisabine angiogeninandosteoprotegerinaretypeiimusclespecificmyokinesprotectingpancreaticbetacellsagainstproinflammatorycytokines AT dusaulcyrodolphe angiogeninandosteoprotegerinaretypeiimusclespecificmyokinesprotectingpancreaticbetacellsagainstproinflammatorycytokines AT hansenjakobs angiogeninandosteoprotegerinaretypeiimusclespecificmyokinesprotectingpancreaticbetacellsagainstproinflammatorycytokines AT howaldcedric angiogeninandosteoprotegerinaretypeiimusclespecificmyokinesprotectingpancreaticbetacellsagainstproinflammatorycytokines AT dermitzakisemmanouilt angiogeninandosteoprotegerinaretypeiimusclespecificmyokinesprotectingpancreaticbetacellsagainstproinflammatorycytokines AT pedersenbentek angiogeninandosteoprotegerinaretypeiimusclespecificmyokinesprotectingpancreaticbetacellsagainstproinflammatorycytokines AT pingetmichel angiogeninandosteoprotegerinaretypeiimusclespecificmyokinesprotectingpancreaticbetacellsagainstproinflammatorycytokines AT plomgaardpeter angiogeninandosteoprotegerinaretypeiimusclespecificmyokinesprotectingpancreaticbetacellsagainstproinflammatorycytokines AT bouzakrikarim angiogeninandosteoprotegerinaretypeiimusclespecificmyokinesprotectingpancreaticbetacellsagainstproinflammatorycytokines |